Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Merck
Express Scripts
QuintilesIMS
Medtronic
US Department of Justice
Healthtrust
Cantor Fitzgerald

Generated: February 16, 2019

DrugPatentWatch Database Preview

NEULASTA Drug Profile

« Back to Dashboard

US Patents for NEULASTA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial ChemoCentryx, Inc. (Mountain View, CA) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial Amgen Inc. (Thousand Oaks, CA) ➤ Try a Free Trial RX Orphan company
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial Amgen Inc. (Thousand Oaks, CA) ➤ Try a Free Trial RX Orphan company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for NEULASTA

Supplementary Protection Certificates for NEULASTA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
SZ 5/2003 Austria ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM
CA 2003 00002 Denmark ➤ Try a Free Trial
6/2003 Austria ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
91006 Luxembourg ➤ Try a Free Trial
300106 Netherlands ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
10299044 Germany ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/227/001 20020822
02C0048 France ➤ Try a Free Trial PRODUCT NAME: PEGFILGRASTIM; REGISTRATION NO/DATE: EU/1/02/228/001 20020822
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Moodys
Queensland Health
McKinsey
Argus Health
Citi
Fuji
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.